Joint Corp is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The company's principal business is to develop, own, operate, support and manage chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the U.S. The company's clinics provide membership and wellness treatment plans. The company's consumer-focused service model targets the non-acute treatment market, which is part of the chiropractic services market.
  • TickerJYNT
  • ISINUS47973J1025
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States
Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

No changes to the status quo in terms of our expectations and what has been playing out in the markets: continued volatility and consolidation. With support levels holding and market internals remaining healthy, we retain our long-term bullish outlook. • Small-caps are perking up. As the U.S. Dollar stabilizes and fears of a trade war brew, small-caps have begun to show strength relative to large-caps. We recommend increasing exposure to small-caps... see below. • Smaller-cap Health Care is leadership. Broadly speaking, small-caps have recently begun to show strength relative to large-caps, ...

Joint Corp (The): 1 director sold

A director at Joint Corp (The) sold 5,600 shares at 8.165USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board...

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior